Top Clinical Trials companies in Ireland by EBIT Margin

This ranking features the top 6 Clinical Trials companies in Ireland ranked by EBIT Margin, averaging a EBIT Margin of -114.75%, for February 07, 2025.
#
Name
EBIT Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
26.73%
Dec. 31, 2023 USD 31.53 -1.19%

Ireland

2
15.32%
Dec. 31, 2023 USD 124.37 -0.54%

Ireland

3
11.52%
Dec. 31, 2023 USD 199.08 -1.31%

Ireland

4
6.62%
Dec. 31, 2023 USD 70.72 0.21%

Ireland

5
-209.08%
Dec. 31, 2023 USD 14.23 -3.20%

Ireland

6
-539.61%
Dec. 31, 2023 USD 7.90 2.73%

Ireland

Frequently Asked Questions
  • Which Clinical Trials company in Ireland has the highest EBIT Margin ?

    The Clinical Trials company in Ireland with the highest EBIT Margin is Alkermes plc (NasdaqGS: ALKS) at 26.73%.

  • Which Clinical Trials company in Ireland has the lowest EBIT Margin ?

    The Clinical Trials company in Ireland with the lowest EBIT Margin is Avadel Pharmaceuticals plc (NasdaqGM: AVDL) at -539.61%.

SV Wall Street